| abstract |
The present invention discloses novel compounds having the structure of formula (I), which are useful in the treatment of mammalian dependence on addictive substances, for example, on dopamine producing agents such as cocaine, morphine, amphetamine, nicotine, and/or alcohol. addiction. The present invention also discloses pharmaceutical compositions comprising a therapeutically effective amount of a compound of formula (I), and methods of using compounds of formula (I) to treat addiction to dopamine-generating agents. |